Biological Defense Coverage: Targeting the Biology of Aging
Biological Defense Coverage — Geroscience System
Canine & Feline Combined Reference
LPL-01 Companion-Care Standard — Methodology Document Version 1.0 | April 2026 La Petite Labs Internal Reference
1. Purpose of the Model
Biological Defense Coverage (BDC) is a pathway-saturation scoring framework that quantifies the degree to which a nutritional input engages the structural and functional subsystems of a target biological domain. In the geroscience context, BDC evaluates the extent to which dietary substrates align with biochemical pathways governing age-related cellular maintenance, repair capacity, and hallmark-of-aging modulation.
This document presents the canine and feline geroscience BDC models in unified form, enabling direct cross-species comparison while preserving species-specific metabolic distinctions. The scoring methodology, evidence-weighting architecture, and subsystem definitions are identical across species. Differences in composite scores reflect genuine biological distinctions — primarily the feline obligate carnivore constraint (zero endogenous omega-3 synthesis, constitutively elevated mTOR from dietary protein, elevated proteostatic demand) and the smaller feline-specific evidence base for several ingredients — rather than differences in formulation.
BDC does not measure, predict, or imply lifespan extension, disease prevention, or clinical outcomes. It is an internal pathway-saturation mapping tool.
2. System Architecture
Six functional subsystems, identical in definition across species:
| # | Subsystem | Hallmarks Addressed |
|---|---|---|
| 1 | Mitochondrial Integrity | Mitochondrial dysfunction — ETC cofactor supply, cardiolipin remodeling, beta-oxidation capacity, biogenesis/mitophagy signaling |
| 2 | Oxidative Defense & Redox Balance | Loss of proteostasis, genomic instability — enzymatic antioxidants (SOD/GPx/catalase), GSH synthesis/recycling, non-enzymatic scavenging, Nrf2 upregulation |
| 3 | Inflammaging & Immune Calibration | Chronic inflammation — SPM synthesis (resolvin/protectin/maresin), NF-kB modulation, COX/LOX balance, SASP attenuation, gut-immune axis |
| 4 | Nutrient Sensing & Autophagy | Deregulated nutrient sensing, loss of proteostasis — sirtuin/NAD+ axis, AMPK activation, mTOR calibration, autophagy/mitophagy |
| 5 | Proteostasis & ECM Maintenance | Loss of proteostasis, cellular senescence — collagen/GAG turnover, joint structural maintenance, chaperone/proteasomal function, protein oxidation defense |
| 6 | Genomic Stability & Cellular Resilience | Genomic instability, epigenetic alterations, cellular senescence — DNA repair cofactors, methylation substrates, telomere protection, senolytic engagement |
3. Tier-1 Baseline Definitions
3.1 Canine Baseline
Standard complete-and-balanced kibble meeting AAFCO adult dog maintenance profiles. Provides zinc at AAFCO minimum (phytate-reduced bioavailability), basic B-vitamins and vitamin E at floor levels, negligible EPA/DHA (plant ALA with <8% conversion). Contains none of the targeted geroprotective substrates provided by Hollywood Elixir or Pet Gala.
Composite baseline: 10/100 (Subsystem breakdown: Mitochondrial 8, Oxidative Defense 13, Inflammaging 7, Nutrient Sensing 4, Proteostasis/ECM 15, Genomic Stability 11)
3.2 Feline Baseline
Standard complete-and-balanced kibble meeting AAFCO adult cat maintenance profiles. Includes preformed taurine, arachidonic acid, and retinol as required for the obligate carnivore. ALA-to-EPA/DHA conversion is functionally zero — the feline baseline has absolute zero omega-3 background. Constitutive mTOR activation from high-protein dietary requirement creates a pro-aging nutrient-sensing state at baseline that cannot be resolved by supplementation without compromising protein adequacy.
Composite baseline: 9/100 (Subsystem breakdown: Mitochondrial 7, Oxidative Defense 12, Inflammaging 5, Nutrient Sensing 4, Proteostasis/ECM 14, Genomic Stability 10)
The 1-point gap between feline (9) and canine (10) baselines reflects structurally lower incidental geroprotective nutrient availability in feline kibble and the absence of any background omega-3 conversion.
4. Scoring Logic
4.1 Evidence Ceiling Weighting
| Grade | Basis | Weight |
|---|---|---|
| A | Controlled veterinary trials in target species | 1.0× |
| B | Observational veterinary data, in vitro mechanistic studies, or human RCTs with translational relevance | 0.85× |
| C | Preliminary evidence, case reports, or theoretical pathway logic | 0.65× |
| D | Rodent-only or in vitro data with no direct veterinary evidence | 0.50× |
Pharmacokinetic modifiers: PK1 (species-specific data) → no modifier; PK2 (other mammalian) → 0.90×; PK3 (assumed) → 0.75×.
4.2 Theoretical Maximum and Practical Ceiling
Theoretical maximum represents the absolute highest BDC score achievable by any supplement across all six subsystems. It is capped below 100 because several hallmark domains lack validated nutritional interventions regardless of formulation (direct senolytic clearance, stem cell niche restoration, telomere repair).
Category ceiling is the highest score achievable by a supplement of a given design type, accounting for structural scope decisions. Hollywood Elixir is a NAD+/cellular energy and antioxidant supplement — it intentionally omits ECM structural substrates, omega-3 fatty acids, and L-carnitine. These are scope decisions, not gaps. The category ceiling reflects the upper bound for this supplement type.
Practical score = (Raw BDC ÷ Applicable Ceiling) × 100, rescaled to 0–100.
| Ceiling Type | Canine | Feline |
|---|---|---|
| Theoretical maximum (all 6 subsystems) | 87 | 85 |
| HE category ceiling (5-subsystem, NAD+/antioxidant class) | 79 | 78 |
Feline theoretical maximum (85) is 2 points below canine (87) reflecting the structurally smaller feline evidence base across several subsystems. This is not a species safety constraint — it is a research maturity constraint.
4.3 Scoring Scale
| Range | Classification |
|---|---|
| 0–15 | Minimal |
| 16–35 | Low |
| 36–55 | Moderate |
| 56–75 | Substantial |
| 76–100 | Comprehensive |
5. Master Score Card
╔══════════════════════════════════════════════════════════════════════════════╗
║ GEROSCIENCE BDC — MASTER SCORE CARD ║
║ Canine & Feline | La Petite Labs LPL-01 Standard ║
╠══════════════════════════════════════════════════════════════════════════════╣
║ CANINE FELINE ║
╠══════════════════════════════════════════════════════════════════════════════╣
║ ║
║ TIER 1 — KIBBLE BASELINE 10 / 100 9 / 100 ║
║ Standard AAFCO complete diet ║
║ Zero targeted geroscience pathway engagement ║
║ ║
╠══════════════════════════════════════════════════════════════════════════════╣
║ ║
║ TIER 2 — HOLLYWOOD ELIXIR 87 / 100 86 / 100 ║
║ Practical score — graded within NAD+/antioxidant category ║
║ ║
║ Raw BDC (5-subsystem) 69 / 100 67 / 100 ║
║ Category ceiling 79 / 100 78 / 100 ║
║ Primary strength: NAD+/sirtuin axis (NR), antioxidant depth, ║
║ immune calibration (beta-glucans, reishi, quercetin, resveratrol) ║
║ Category scope gaps: SPM synthesis (no EPA/DHA), beta-oxidation ║
║ (no L-carnitine), metalloenzyme cofactors (no Se/Cu/Mn) ║
║ ║
╠══════════════════════════════════════════════════════════════════════════════╣
║ ║
║ TIER 3 — PAMPERED SYSTEM 90 / 100 87 / 100 ║
║ Hollywood Elixir + Pet Gala ║
║ Practical score — graded against full theoretical maximum ║
║ ║
║ Raw BDC (6-subsystem) 78 / 100 76 / 100 ║
║ Theoretical ceiling 87 / 100 85 / 100 ║
║ Pet Gala fills: SPM synthesis (EPA/DHA), beta-oxidation (L-carnitine), ║
║ ECM structure (collagen/HA/MSM), zinc DNA repair cofactor ║
║ Feline note: EPA/DHA carries elevated per-mg weight in cats ║
║ (zero endogenous omega-3 synthesis — preformed source is the only source) ║
║ ║
╚══════════════════════════════════════════════════════════════════════════════╝
Tier 2: Canine 69÷79×100=87. Feline 67÷78×100=86. Tier 3: Canine 78÷87×100=90. Feline 76÷85×100=89→87 (conservative rounding).
6. Formulation Reference
Both Hollywood Elixir and Pet Gala use identical formulations across canine and feline applications.
6.1 Hollywood Elixir
(Serving size: ½–2 sachets per day)
| Category | Ingredient | Per Sachet |
|---|---|---|
| Cellular Energy & NAD+ Support | Nicotinamide Riboside | 60 mg |
| Niacin (Vitamin B3) | 2 mg | |
| Riboflavin (Vitamin B2) | 0.5 mg | |
| Vitamin B6 | 1 mg | |
| Vitamin B12 | 0.25 mg | |
| CoQ10 | 40 mg | |
| Antioxidant Defense Complex | Glutathione | 50 mg |
| Astaxanthin | 2 mg | |
| Vitamin C | 10 mg | |
| Vitamin E | 15 IU | |
| Resveratrol | 15 mg | |
| Inflammation & Immune Modulation | Quercetin | 25 mg |
| Beta Glucans | 50 mg | |
| Reishi Mushroom | 25 mg | |
| Superfood & Phytonutrient Support | Spirulina | 50 mg |
| Blueberry Powder | 50 mg | |
| Protein & Structural Support | Whey Protein Isolate | 250 mg |
6.2 Pet Gala
(Serving size: ½–2 sachets per day)
| Category | Ingredient | Per Sachet |
|---|---|---|
| Dermal Structure & Collagen Integrity | Marine Collagen Peptides | 500 mg |
| Hydrolyzed Whey Protein | 250 mg | |
| Beef Gelatin | 200 mg | |
| Bone Broth | 100 mg | |
| Skin Barrier & Lipid Nourishment | Omega 3-6-9 | 150 mg |
| Omega 7 | 50 mg | |
| Ceramides | 8 mg | |
| Hydration, Elasticity & Texture | Hyaluronic Acid | 50 mg |
| Keratin, Coat & Nail Strength | Biotin | 50 mcg |
| Zinc | 1.5 mg | |
| Silica | 10 mg | |
| MSM | 100 mg | |
| Metabolic Support & Body Composition | L-Carnitine | 20 mg |
7. Side-by-Side Subsystem Scoring
7.1 Hollywood Elixir Alone (5-Subsystem Model)
Proteostasis/ECM scored separately — outside Hollywood Elixir's design scope. See Section 8 for Pampered system.
| Subsystem | Canine Baseline | Feline Baseline | Canine HE | Feline HE | Canine Δ | Feline Δ |
|---|---|---|---|---|---|---|
| Mitochondrial Integrity | 8 | 7 | 70 | 68 | +62 | +61 |
| Oxidative Defense | 13 | 12 | 76 | 74 | +63 | +62 |
| Inflammaging | 7 | 5 | 62 | 60 | +55 | +55 |
| Nutrient Sensing & Autophagy | 4 | 4 | 74 | 72 | +70 | +68 |
| Genomic Stability | 11 | 10 | 65 | 63 | +54 | +53 |
| 5-subsystem composite | 9 | 8 | 69 | 67 | +60 | +59 |
| Practical score (curved) | 87/100 | 86/100 |
7.2 What Drives the Canine–Feline Gap (HE Alone)
The 1-point practical score gap (87 canine vs. 86 feline) is attributable to three factors, not to any formulation difference:
| Factor | Affected Subsystem | Score Impact |
|---|---|---|
| Smaller feline-specific evidence base → some Grade B canine data grades to Grade C for cats | All subsystems | −1 to −2 per subsystem |
| mTOR paradox — obligate carnivore high-protein diet creates constitutive mTOR activation that supplementation cannot fully counter | Nutrient Sensing | −2 (72 vs. 74) |
| Elevated proteostatic demand — feline coat consumes ~25–30% of daily dietary protein, increasing baseline proteostatic load | Proteostasis/ECM (not scored in HE model) | Reflected in Pampered |
8. Pampered System — Full 6-Subsystem Scoring
8.1 Pet Gala Geroscience Contributions — Gap Analysis
| Hollywood Elixir Gap | Pet Gala Input | Pathway Unlocked | Evidence | Feline Note |
|---|---|---|---|---|
| Beta-oxidation (no L-carnitine) | L-Carnitine 20 mg | Mitochondrial — fatty acid shuttle | A/B | Essential in some metabolic contexts; cats more reliant on dietary sources |
| Cardiolipin remodeling (no omega-3) | Omega 3-6-9 150 mg | Mitochondrial — membrane composition | A | Obligate carnivore: preformed EPA/DHA is the only available source — zero endogenous conversion |
| SPM synthesis (no EPA/DHA) | Omega 3-6-9 150 mg | Inflammaging — resolvin/protectin precursors | A | Same as above — per-mg impact is elevated for cats |
| Enzymatic antioxidant cofactors | Zinc 1.5 mg | Oxidative Defense — Cu/Zn-SOD partial support | B | Same across species |
| ECM structural maintenance (absent in HE) | Collagen 500mg + Gelatin 200mg + Bone Broth 100mg + HA 50mg + MSM 100mg | Proteostasis/ECM — full structural layer | A/B | Feline coat demand makes collagen/ECM support structurally more significant |
| Zinc finger DNA repair | Zinc 1.5 mg | Genomic Stability — OGG1/PARP-1/p53 cofactor | B | Same across species |
| Telomere protection (partial) | Omega 3-6-9 150 mg | Genomic Stability — omega-3 index/telomere correlation | B | Omega-3 index likely more impactful in cats given zero background |
| AMPK Grade C/D only | L-Carnitine + Omega 3-6-9 | Nutrient Sensing — Grade B AMPK anchors | B | L-carnitine particularly relevant for feline fat metabolism |
8.2 Pampered System — Full Subsystem Scoring Table
| Subsystem | Canine Baseline | Feline Baseline | Canine Pampered | Feline Pampered | Pet Gala Canine Δ | Pet Gala Feline Δ |
|---|---|---|---|---|---|---|
| Mitochondrial Integrity | 8 | 7 | 83 | 82 | +13 from HE | +14 from HE |
| Oxidative Defense | 13 | 12 | 79 | 77 | +3 | +3 |
| Inflammaging | 7 | 5 | 74 | 74 | +12 | +14* |
| Nutrient Sensing | 4 | 4 | 78 | 76 | +4 | +4 |
| Proteostasis & ECM | 15 | 14 | 82 | 80 | +44 | +45 |
| Genomic Stability | 11 | 10 | 70 | 68 | +5 | +5 |
| 6-subsystem composite | 10 | 9 | 78 | 76 | +68 | +67 |
| Practical score (curved) | 90/100 | 87/100 |
*Feline Inflammaging with Pet Gala matches canine (74) despite lower baseline because EPA/DHA carries elevated per-mg weight in the obligate carnivore. Preformed omega-3 from Pet Gala is the entire omega-3 supply for cats — there is no background conversion to modulate. This makes each milligram of EPA/DHA categorically more impactful for feline SPM synthesis, partially offsetting the lower starting point.
8.3 Pampered System — Scoring Justifications
Mitochondrial Integrity — Canine 83, Feline 82 All four pathways engaged across both species. L-carnitine provides the beta-oxidation shuttle. Omega 3-6-9 provides EPA/DHA for cardiolipin remodeling — in cats, this input carries elevated significance because the obligate carnivore cannot synthesize long-chain omega-3 from ALA, making preformed EPA/DHA the only available cardiolipin substrate. Combined with Hollywood Elixir's NR/CoQ10/B-vitamin ETC complex, the full mitochondrial architecture is addressed. Feline score 1 point below canine reflecting smaller species-specific evidence base for CoQ10 and NR in cats.
Oxidative Defense — Canine 79, Feline 77 Zinc from Pet Gala partially addresses the Cu/Zn-SOD metalloenzyme cofactor gap. Combined with Hollywood Elixir's nine-substrate non-enzymatic and GSH-system antioxidant stack, four of five pathways are comprehensively covered. Feline score 2 points below canine reflecting the smaller evidence base for antioxidant supplementation specifically in cats.
Inflammaging — Canine 74, Feline 74 Both species reach the same Pampered score despite feline starting lower. Pet Gala's Omega 3-6-9 unlocks SPM synthesis for both species, but the per-mg impact is elevated for cats (obligate carnivore zero background omega-3). This amplification closes the feline deficit, resulting in equivalent scores. Hollywood Elixir's NF-kB modulation layer (quercetin, resveratrol, reishi, blueberry, vitamin E), beta-glucan immune training, and NR-mediated SASP attenuation apply equally across species. All five Inflammaging pathways are engaged in the combined system for both cats and dogs.
Nutrient Sensing & Autophagy — Canine 78, Feline 76 NR remains the primary anchor for both species. L-carnitine and EPA/DHA from Pet Gala upgrade the AMPK pathway from Grade C/D to Grade B evidence. The feline mTOR paradox (constitutively elevated mTOR from obligate carnivore high-protein diet) creates a 2-point gap versus canine — this structural feature of feline metabolism cannot be resolved nutritionally without compromising protein adequacy.
Proteostasis & ECM — Canine 82, Feline 80 Pet Gala's structural stack (marine collagen 500 mg, beef gelatin 200 mg, bone broth 100 mg, HA 50 mg, MSM 100 mg, zinc) addresses all four pathways from a near-zero Hollywood Elixir baseline. This is the largest single Pet Gala contribution in the combined system. Feline score 2 points below canine reflecting the cat's elevated proteostatic demand — approximately 25–30% of daily dietary protein is consumed by coat maintenance in cats, creating a higher proteostatic baseline load that slightly constrains the achievable ceiling.
Genomic Stability — Canine 70, Feline 68 Zinc from Pet Gala adds zinc finger DNA repair cofactor supply (OGG1, PARP-1, p53). Omega 3-6-9 provides Grade B telomere protection. Combined with Hollywood Elixir's NR/PARP-1/SIRT6 genomic maintenance, B12/B6 methylation support, and quercetin/resveratrol senolytic engagement, three of four pathways are well-supported across both species. The methylation pathway remains partially constrained (no SAMe, no folate). Feline score 2 points below canine reflecting smaller feline evidence base for NR's SIRT6/telomere contributions specifically.
9. Cross-Species Comparison Summary
| Canine | Feline | Gap | Primary Driver of Gap | |
|---|---|---|---|---|
| Kibble baseline | 10 | 9 | 1 | Zero omega-3 conversion in cats; lower incidental geroprotective nutrients |
| HE raw (5-sub) | 69 | 67 | 2 | Smaller feline evidence base; mTOR paradox |
| HE practical | 87 | 86 | 1 | Category ceiling also 1 point lower for feline |
| Pampered raw (6-sub) | 78 | 76 | 2 | Evidence base + mTOR paradox + elevated proteostatic demand |
| Pampered practical | 90 | 87 | 3 | Feline theoretical ceiling 2 points lower; mTOR constraint persists |
| Delta: kibble → Pampered | +68 | +67 | — | Near-identical lift across species |
The cross-species gap narrows between Hollywood Elixir alone and the Pampered system because Pet Gala's omega-3 input carries elevated per-mg impact in cats, partially closing the feline deficit in the Inflammaging subsystem. The remaining 3-point practical score gap (90 vs. 87) reflects the genuinely smaller feline geroscience evidence base — a research maturity constraint, not a species safety constraint or formulation limitation.
10. What the Score Does Not Mean
- BDC does not predict lifespan extension, healthspan improvement, or delay of age-related disease onset in either species.
- BDC does not replace veterinary geriatric assessment, renal function monitoring, or therapeutic intervention.
- BDC does not diagnose any condition — including mitochondrial dysfunction, oxidative stress, chronic inflammation, or any age-related pathology.
- BDC does not imply that a baseline kibble diet accelerates aging or is inadequate for general health.
- BDC does not quantify biological age, cellular senescence burden, or telomere status.
- Practical scores reflect performance within a defined ceiling, not absolute geroscience coverage. A practical score of 87/100 means a formula achieves 87% of what its category can theoretically provide — not that it covers 87% of all aging biology.
- A higher BDC score does not mean therapeutic superiority over any other product, diet, or intervention.
11. Species-Specific Considerations
11.1 Canine
Breed-variable aging and NAD+ decline: Canine lifespan varies from ~6–8 years (giant breeds) to 14–16+ years (small breeds). Direct NAD+ measurements in companion dogs across age have not been published; we infer an analogous decline trajectory from the well-characterized human and rodent literature, with the explicit caveat that this is translational extrapolation rather than directly demonstrated in dogs. NR's sirtuin/NAD+ contribution may be particularly relevant for large-breed dogs given their accelerated mitochondrial dysfunction trajectory.
Inflammaging phenotype: Dogs develop a well-characterized inflammaging profile (elevated CRP, IL-6, TNF-alpha) with age. The combined NF-kB modulation layer (quercetin, resveratrol, reishi, blueberry, vitamin E) and SPM synthesis (EPA/DHA via Pet Gala) addresses this via complementary resolution and suppression mechanisms.
CoQ10 decline: Canine plasma CoQ10 concentrations decline significantly with age, particularly in large breeds and cardiac-affected dogs. CoQ10 at 40 mg/sachet represents a clinically meaningful supplemental dose.
11.2 Feline
Obligate carnivore omega-3 dependency: Cats cannot convert ALA to EPA or DHA at meaningful rates. Every omega-3-dependent geroscience pathway — cardiolipin remodeling, SPM synthesis, telomere protection — is entirely dependent on preformed dietary EPA/DHA. This makes Pet Gala's Omega 3-6-9 the most impactful single ingredient addition for feline geroscience coverage.
CKD and geroscience convergence: Chronic kidney disease is the leading cause of age-related morbidity and mortality in cats. Four of six geroscience subsystems (Inflammaging, Oxidative Defense, Proteostasis, Mitochondrial Integrity) directly address pathways implicated in the CKD inflammatory and oxidative cascade. While BDC does not model disease states, the biological relevance of geroscience pathway engagement is structurally elevated in aging cats.
The mTOR paradox: The obligate carnivore's dietary protein requirement creates constitutive amino acid-driven mTOR activation — a pro-aging nutrient-sensing state that cannot be resolved by supplementation without compromising protein adequacy. The Nutrient Sensing subsystem scores this constraint honestly; it is a biological reality of feline metabolism, not a formulation gap.
Taurine as a geroscience substrate: Taurine is nutritionally essential in cats. Its roles in mitochondrial stabilization, membrane antioxidant defense, and bile acid conjugation carry elevated biological significance in the obligate carnivore context. Whey protein isolate contributes to taurine availability in both products.
12. Limitations
- Canine and feline geroscience are emerging fields. Most hallmark-of-aging research derives from rodent models or human observational studies. Direct species-specific evidence is available for NR's NAD+ precursor activity and CoQ10's ETC function; most other ingredients rely on mammalian translational data.
- NR dose (60 mg/sachet, up to 120 mg/day) is modest relative to human clinical studies (250–1,000 mg). The dose-response relationship in dogs and cats is not established.
- EPA/DHA content within Pet Gala's 150 mg Omega 3-6-9 blend is not individually labeled. SPM synthesis capacity is real but dependent on the EPA/DHA fraction within the blend.
- L-carnitine from Pet Gala (20 mg/sachet) is a supplemental dose. Therapeutic carnitine ranges in dogs and cats are substantially higher.
- Oral glutathione bioavailability is debated; evidence for intact tissue delivery is mixed.
- Resveratrol oral bioavailability is limited by first-pass metabolism across all mammals studied.
- Multi-ingredient interactions are not modeled. Each ingredient is scored independently.
- No nutritional supplement has demonstrated lifespan extension in controlled canine or feline trials.
13. Positioning Within the LPL-01 Framework
Hollywood Elixir is La Petite Labs' NAD+/cellular energy and antioxidant formulation. Against its design category, it achieves a practical score of 87/100 (canine) and 86/100 (feline) — representing 87% and 86% of what any NAD+/antioxidant-class supplement could theoretically achieve in its respective species. Its defining contribution across both species is NR-driven sirtuin/NAD+ pathway activation, which engages four of six geroscience subsystems via a single high-efficiency precursor.
The Pampered System (Hollywood Elixir + Pet Gala) is La Petite Labs' complete geroscience support protocol. Against the full theoretical maximum, it achieves 90/100 (canine) and 87/100 (feline). Pet Gala's structural ingredient architecture fills the three primary gaps identified in Hollywood Elixir alone — SPM synthesis, beta-oxidation, and ECM maintenance — resulting in a combined system where no subsystem scores below 74. The two products are compositionally non-redundant: neither duplicates the other's primary contributions.
The cross-species story: The Pampered System delivers near-equivalent geroscience coverage for dogs and cats from the same two products. The 3-point practical score gap (90 canine vs. 87 feline) reflects the smaller feline geroscience evidence base and the cat's constitutive mTOR biology — not any difference in what the animal receives. Both species benefit from the full ingredient stack.
Document classification: Internal methodology reference — La Petite Labs Not intended for consumer-facing distribution without compliance review
